| Table 22-7. Androgen ablation therapy for prostate cancer. | ||||
| Level | Agent | Dose Route | Dose (mg) | Frequency |
| Pituitary | ||||
| Diethylstilbestrol | Oral | 1-3 | Daily | |
| Goserelin | Subcutaneous | 10.8 | Every 3 months | |
| Goserelin | Subcutaneous | 3.6 | Every month | |
| Leuprolide | Intramuscular | 22.5 | Every 3 months | |
| Leuprolide | Intramuscular | 7.5 | Every month | |
| Adrenal | ||||
| Ketoconazole | Oral | 400 | Daily | |
| Aminoglutethimide | Oral | 250 | Four times a day | |
| Testicle | ||||
| Orchiectomy | ||||
| Prostate cell | ||||
| Bicalutamide | Oral | 50 | Daily | |
| Flutamide | Oral | 250 | Three times a day | |
| Nilutamide | Oral | 150 | Daily | |